Latest news
FDA Approves mFLUSIVA for Influenza Prevention in Adults Aged 50 Years and Older - Consultant360Consultant360 · Fri, 07 Aug 2026 14:04:32 GMTModerna gets U.S. FDA nod for Influenza Vaccine mFLUSIVA - Mass Market RetailersMass Market Retailers · Fri, 07 Aug 2026 12:15:01 GMTOne year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was - STATSTAT · Thu, 06 Aug 2026 12:15:36 GMTModerna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock - BioSpaceBioSpace · Thu, 06 Aug 2026 11:52:35 GMTU.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season - Business WireBusiness Wire · Thu, 06 Aug 2026 10:45:00 GMTFDA approves first mRNA flu vaccine - The HillThe Hill · Thu, 06 Aug 2026 10:39:00 GMTBlueWind Medical lands FDA clearance for UUI implant with 15-year lifespan - Medical Device NetworkMedical Device Network · Thu, 06 Aug 2026 10:17:11 GMTTaylor Farms linked to 5 other Cyclospora or E.Coli outbreaks in last decade-plus - CNNCNN · Thu, 06 Aug 2026 10:00:29 GMT